Study of IBI363 in Patients with Advanced First-line Gastric Cancer

NCT06610799 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Xiangdong Cheng